Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Chem Biol Interact ; 153-154: 231-7, 2005 May 30.
Article in English | MEDLINE | ID: mdl-15885679

ABSTRACT

Epidemiological papers that address an association between benzene exposure and non-Hodgkin lymphoma (NHL) were identified and separated by study design. Eighteen studies contained 21 study groups-11 population-based case-control study groups, 3 nested occupation-based case-control study groups and 7 occupational benzene cohort study groups. Petroleum industry studies were not included. Only two of these 21 study groups showed statistically significant associations. However, these were among workers with multiple exposures across industries. Eleven of the 21 study groups presented ratios less than one, two equaled one, and eight were greater than one. Over all, about as many cases were observed (404) as expected (390.0) for an observed to expected ratio of 1.04 (0.94-1.14). After removal of the studies with multiple chemical exposures problems, the observed was 359 cases with 373.2 cases expected, yielding an odds ratio of 0.96 (0.86-1.06). Further assessment of an association with NHL should document the benzene exposure and separate out the contribution of non-benzene exposures.


Subject(s)
Air Pollutants, Occupational/toxicity , Benzene/toxicity , Lymphoma, Non-Hodgkin/etiology , Occupational Exposure , Case-Control Studies , Cohort Studies , Humans , Industry , Lymphoma, Non-Hodgkin/epidemiology , Odds Ratio
3.
Teratology ; 62(6): 429-31, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11091365

ABSTRACT

BACKGROUND: The effect of perchlorate in drinking water on neonatal blood thyroid-stimulating hormone (thyrotropin; TSH) levels was examined for Las Vegas and Reno, Nevada. METHODS: The neonatal blood TSH levels in Las Vegas (with up to 15 microg/L (ppb) perchlorate in drinking water) and in Reno (with no perchlorate detected in the drinking water) from December 1998 to October 1999 were analyzed and compared. The study samples were from newborns in their first month of life (excluding the first day of life) with birth weights of 2, 500-4,500 g. A multivariate analysis of logarithmically transformed TSH levels was used to compare the mean TSH levels between Las Vegas and Reno newborns, with age and sex being controlled as potential confounders. RESULTS: This study of neonatal TSH levels in the first month of life found no effect from living in the areas with environmental perchlorate exposures of

Subject(s)
Fetal Blood/chemistry , Fresh Water/analysis , Perchlorates/analysis , Sodium Compounds/analysis , Thyrotropin/blood , Water Pollutants, Chemical/analysis , Water Supply/analysis , Age Factors , Birth Weight , Confounding Factors, Epidemiologic , Environmental Exposure , Female , Humans , Infant, Newborn , Male , Nevada , Sensitivity and Specificity , Sex Factors
6.
Int Arch Occup Environ Health ; 68(6): 484-94, 1996.
Article in English | MEDLINE | ID: mdl-8891790

ABSTRACT

Induction of cancer by inorganic arsenic occurs inconsistently between species and between routes of exposure, and it exhibits different dose-response relationships between different target organs. Inhaled or ingested arsenic causes cancer in humans but not in other species. Inhaled arsenic primarily induces lung cancer, whereas ingested arsenic induces cancer at multiple sites, including the skin and various other organs. Cancer potency appears to vary by route of exposure (ingestion or inhalation) and by organ site, and increases markedly at higher exposures in some instances. To understand what might explain these inconsistencies, we reviewed several hypotheses about the mechanism of cancer induction by arsenic. Arsenic disposition does not provide satisfactory explanations. Induction of cell proliferation by arsenic is a mechanism of carcinogenesis that is biologically plausible and compatible with differential effects for species or differential dose rates for organ sites. The presence of other carcinogens, or risk modifiers, at levels that correlate with arsenic in drinking water supplies, may be a factor in all three inconsistencies: interspecies specificity, organ sensitivity to route of administration, and organ sensitivity to dose rate.


Subject(s)
Arsenic/adverse effects , Kidney Neoplasms/chemically induced , Linear Models , Skin Neoplasms/chemically induced , Urinary Bladder Neoplasms/chemically induced , Water Pollutants/adverse effects , Aged , Dose-Response Relationship, Drug , Female , Humans , Kidney Neoplasms/epidemiology , Male , Prevalence , Risk Assessment , Risk Factors , Skin Neoplasms/epidemiology , Survival Rate , Urinary Bladder Neoplasms/epidemiology
9.
Environ Health Perspect ; 82: 289-97, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2676500

ABSTRACT

This paper examines recent risk assessments for benzene and observes a number of inconsistencies within the study and consistencies between studies that should effect the quantitative determination of the risk from benzene exposure. Comparisons across studies show that only acute myeloid leukemia (AML) is found to be consistently in excess with significant benzene exposure. The data from the Pliofilm study that forms the basis of most quantitative assessments reveal that all the AML cases came from only one of the three studied plants and that all the benzene exposure data came from the other plants. Hematological data from the 1940s from the plant from which almost all of the industrial hygiene exposure data come do not correlate well with the originally published exposure estimates but do correlate well with an alternative set of exposure estimates that are much greater than those estimates originally published. Temporal relationships within the study are not consistent with those of other studies. The dose-response relationship is strongly nonlinear. Other data suggest that the leukemogenic effect of benzene is nonlinear and may derive from a threshold toxicity.


Subject(s)
Benzene/adverse effects , Leukemia, Myeloid, Acute/chemically induced , Leukemia/chemically induced , Occupational Diseases/chemically induced , Humans , Leukemia/mortality , Leukemia, Myeloid, Acute/mortality , Occupational Diseases/mortality , Risk
10.
Environ Health Perspect ; 82: 283-7, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2792047

ABSTRACT

This paper reviews 14 risk assessments that use the data from descriptions by Rinsky, Young, and co-workers of benzene-associated leukemias among a group of rubber hydrochloride workers in Ohio. The leukemogenic risks of benzene estimated in these assessments differ. The assessors use different assumptions (parameters, confounding factors, or formulas), which account for the differences in risk. The purpose of the review is to determine whether the major source of uncertainty in assessments of benzene risk arises from data, method, or concept. The results show that methodological differences dominate the other two potential sources with respect to impact on risk magnitude.


Subject(s)
Benzene/adverse effects , Leukemia, Myeloid, Acute/chemically induced , Occupational Diseases/chemically induced , Epidemiologic Methods , Humans , Leukemia, Myeloid, Acute/epidemiology , Middle Aged , Occupational Diseases/epidemiology , Probability , Risk , Rubber
11.
Ann N Y Acad Sci ; 284: 463-71, 1977 Mar 04.
Article in English | MEDLINE | ID: mdl-280145

ABSTRACT

SN11841 [4'-(9-acridinylamino)-methanesulfon-m-aniside] is an antitumor compound discovered by B.F. Cain. The LD50 for BALB/c mice with single intraperitoneal dosage is approximately 25 mg/kg. RLV-(Rauscher leukemia virus)-induced splenomegaly, a disease indicator in BALB/c mice, is inhibited at SN11841 doses not causing acute mortality. The life span of RLV-infected mice increases at some SN11841 doses. SN11841 does not have direct, or virolytic effects on RLV under conditions approximating those of antiviral effectiveness. SN11841 is cytotoxic for cells in tissue culture, as measured by inhibition of growth rate or vital dye uptake. At nontoxic concentrations SN11841 has no effect on RLV infectivity for murine cells, as determined by XC-cell induced syncytium formation. SN11841 has antiviral activity against vaccinia virus in tissue culture but is inactive against herpes simplex (Type 1), vesicular stomatitis, encephalomyocarditis, or reoviruses. SN11841 apparently does not act by inducing interferon. SN11841 is chemically labile, particularly in the presence of sulfhydryl compounds, but the degradation products resulting from prolonged storage in media are neither cytotoxic nor antiviral.


Subject(s)
Acridines/pharmacology , Antineoplastic Agents/pharmacology , Antiviral Agents , Acridines/therapeutic use , Animals , Antineoplastic Agents/therapeutic use , Cell Survival/drug effects , Cells, Cultured , Leukemia, Experimental/complications , Leukemia, Experimental/drug therapy , Leukemia, Experimental/microbiology , Male , Mice , Mice, Inbred BALB C , Phenylenediamines/pharmacology , Phenylenediamines/therapeutic use , Rauscher Virus , Splenomegaly/etiology , Splenomegaly/prevention & control , Virus Replication/drug effects
12.
Antimicrob Agents Chemother ; 11(2): 312-7, 1977 Feb.
Article in English | MEDLINE | ID: mdl-848938

ABSTRACT

Evidence was obtained which indicates that the lethal effect of 5-iodouracil (IUra) on bacteriophage T4 is not due to a mutagenic process. T4td8rII (thymine requiring, rapid lysis) double mutants were constructed. Reversion of T4td8rII to r(+) was measured. First, reversion by growth in the presence of the structural analogues chlorouracil (ClUra) and bromouracil (BrUra) did not correlate with their relative lethal effects (for mutagenesis: IUra

Subject(s)
Coliphages/drug effects , Mutagens , Uracil/analogs & derivatives , Uracil/pharmacology , Kinetics , Structure-Activity Relationship
13.
Chem Biol Interact ; 12(2): 197-210, 1976 Feb.
Article in English | MEDLINE | ID: mdl-764990

ABSTRACT

5-Iodouracil (IUra)-substituted progeny bacteriophage T4td8 were grown under conditions such that, upon CsCl equilibrium isopycnic gradient centrifugation, progeny with density distributions about the median similar to that of unsubstituted phage are obtained. In the absence of light a monotonic relationship exists between decreasing progeny viability and increasing percent IUra substitution. IUra is equivalent to thymine as a growth factor on a molar basis, and at concentrations of IUra plus thymine above that required for maximum particle production, the percent IUra substitution in phage DNA is determined by the mole fraction of IUra in the medium. The lethal effects of 5-iodo-2'-deoxyuridine (IdUrd) and IUra are equivalent, and are not produced by a direct effect on the phage particles. At equivalent percent substitution in phage DNA the order of lethality is IUra greater than 5-bromouracil (BrUra) greater than 5-chlorouracil (ClUra). There is no interference with the transfer of thymine from host cell to progeny phage by the presence of IUra in the medium, and IUra affects neither the time of lysis nor the content of phage DNA in the infected cells.


Subject(s)
Coliphages/drug effects , Uracil/analogs & derivatives , Uracil/pharmacology , Virus Replication/drug effects , Centrifugation, Density Gradient , Coliphages/metabolism , Darkness , Escherichia coli/drug effects , Escherichia coli/metabolism
14.
Antimicrob Agents Chemother ; 8(5): 558-63, 1975 Nov.
Article in English | MEDLINE | ID: mdl-1108777

ABSTRACT

Nonviable, 5-iodouracil (IUra)-substituted bacteriophage T4td8 can be multiplicity reactivated. The data indicate that two nonviable, IUra-substituted T4td8 phage can complement each other intracellularly to produce viable progeny. Phage particles in lysates of T4td8-infected Escherichia coli BT(-), prepared in the presence of varying mole fractions of IUra plus thymine, were examined by infecting with low and high dilutions of lysate. The yields of multiplicity reactivable particles were identical, regardless of the mole fractions of IUra present in the growth media. However, the yields of viable phage, measured at low multiplicities of infection, decreased with increasing mole fraction of IUra. The results are consistent with the hypothesis that the lethal effect of IUra is a consequence of its incorporation into DNA. Further, the IUra-induced lesion cannot involve genetic damage that shuts off expression at a single region of the genome.


Subject(s)
Coliphages/drug effects , Uracil/analogs & derivatives , Uracil/pharmacology , Coliphages/metabolism , Culture Media , Escherichia coli/drug effects , Mutation , Thymine/metabolism , Virus Replication/drug effects
15.
Res Commun Chem Pathol Pharmacol ; 10(3): 525-32, 1975 Mar.
Article in English | MEDLINE | ID: mdl-166420

ABSTRACT

6-(P-hydroxyphenylazo)-uracil (HPUra) reduced by dithiothreitol inhibited AMV or RLV virion associated exogenous RNA-dependent DNA polymerase reactions. However, the inhibition was variable from experiment to experiment and was not consistent with the base specificity of HPUra seen for inhibition of gram positive DNA-dependent DNA polymerases. Increasing the concentration of dithiothreitol reversed the inhibition. Furthermore, at non-toxic concentrations, HPUra did not influence the plating efficiency of RLV in tissue culture, as measured by the ability to induce foci on sarcoma virus positive-leukemia virus negative cells. Oxidation of dithiothreitol in the presence or absence of HPUra was followed spectrophotometrically under enzyme conditions. HPUra catalyzed the oxidation of dithiothreitol under these conditions. Since dithiothreitol is required for optimum reaction rates, as well as complete disruption of virus in some polymerase assay systems, the oxidation of dithiothreitol in the presence of HPUra is sufficient to explain the inhibition seen.


Subject(s)
DNA Nucleotidyltransferases/antagonists & inhibitors , Dithiothreitol/pharmacology , Hydroxyphenylazouracil , Uracil/analogs & derivatives , Animals , Antiviral Agents/pharmacology , Avian Myeloblastosis Virus/drug effects , Cells, Cultured , Hydroxyphenylazouracil/pharmacology , Leukemia Virus, Murine/drug effects , Mice , Oxidation-Reduction , RNA, Viral
17.
Antimicrob Agents Chemother ; 6(5): 594-7, 1974 Nov.
Article in English | MEDLINE | ID: mdl-15825311

ABSTRACT

The in vitro antivirion activities of five different streptovaricin complex lots against the polycythemic strain of the Friend virus were evaluated. The assay system was based on the inhibition of the Friend virus-induced spleen foci. The virus inactivation process was shown to be susceptible to variation in temperature, pH, and time. The antivirion activity and the acute toxicity for mice, as well as the optical properties of these streptovaricin complexes, do not co-vary; this suggests that their biological activities are not associated with a single molecular structure. In addition, the antivirion activity of the five preparations of streptovaricin complex differs about 30-fold, indicating that this activity does not reside in a major component of the complex.


Subject(s)
Antiviral Agents/pharmacology , Friend murine leukemia virus/drug effects , Streptovaricin/pharmacology , Virion/drug effects , Animals , Hydrogen-Ion Concentration , Lethal Dose 50 , Male , Mice , Mice, Inbred BALB C , Streptovaricin/toxicity , Temperature
18.
Infect Immun ; 10(5): 1057-61, 1974 Nov.
Article in English | MEDLINE | ID: mdl-16558089

ABSTRACT

The extracellular, acid-soluble cell products (EASCP) from Newcastle disease virus-infected L(929) cells contain both interferon, defined as antiviral activity, and refractoriness inducing principle, defined as an activity that inhibits interferon production. L cells pretreated with EASCP and then infected with Newcastle disease virus give rise to EASCP with decreased amounts of interferon but an increased ratio of refractoriness inducing principle activity to interferon activity in a dose related manner. The antiviral activity of an EASCP preparation is not dependent upon its refractoriness inducing principle level, but is entirely dependent on its interferon content. Our results provide additional evidence that interferon and refractoriness inducing principle are different biological entities and not polymorphic functions of the interferon molecule.

SELECTION OF CITATIONS
SEARCH DETAIL
...